Donate

Australia’s national cancer

Every year, over 17,000 Australians are diagnosed with melanoma and sadly, around 1,300 Australians will lose their life to this deadly cancer that can affect young and old.

A cure is on the horizon

During the past 10 years, there has been a revolution in treatments for melanoma and skin cancer. For many, a melanoma diagnosis is no longer a death sentence, but the path to being cured is not always straightforward.

The first wave of industry-driven innovation in melanoma and skin cancer treatments led by major pharmaceutical companies has now receded. Although we now have a range of new therapies, we are still discovering how to optimally use these new treatments for patients and that is why our clinical trials are so important.

Clinical trials save lives

The clinical trials coordinated by MASC Trials are answering the many research questions emerging from the introduction of combined cancer treatment methods, such as our GoTHAM and CHARLI clinical trials.

Our clinical trials also explore how to improve diagnosis and how to prevent melanoma and skin cancer from reoccurring, such as our IMAGE trial and SiroSkin trials.

Surgical intervention – once the only option for melanoma and skin cancer patients – is now being refined through our world-wide MelMarT-II trial that will reduce the potential for disfigurement for patients and the burden on the healthcare system.

Our clinical trials are directly improving the lives of melanoma and skin cancer patients in Australia and around the world, while also reducing the burden on the healthcare system.

If you would like to make a donation by cheque or bank transfer, please email hello@masc.org.au for further details.

All donations to MASC Trials over $2 are tax deductible and you will be sent a tax receipt.

MASC Trials is a registered not-for-profit research organisation (company limited by guarantee), and has an academic affiliation with Monash University, with a dedicated centre supporting its research activities, the Melanoma and Skin Cancer Research Centre, within the School of Public Health and Preventative Medicine.